QIPT Earnings Prediction
The chart below shows how QIPT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, QIPT sees a -2.76% change in stock price 10 days leading up to the earnings, and a -4.92% change 10 days following the report. On the earnings day itself, the stock moves by +2.71%. This data can give you a slight idea of what to expect for the next quarter's release.
QIPT Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
52.63M
0.33%
-17.72%
Gross Margin
51.61%
-3.82%
-5.16%
Operating Margin
-3.58%
-1378.57%
-536.59%
Net Margin
-5.91%
134.52%
122.18%
EPS
-0.07
-133.33%
75.00%
No Data Available
QIPT Earnings Analysis
Quipt Home Medical Corp. Ordinary Shares Corporation (QIPT.O) Earnings Conference Call
Positive
Record Revenue Achievement: Fiscal 2024 achieved record revenue of $245.9 million, representing a 16% year-over-year growth.
Adjusted EBITDA Performance: Adjusted EBITDA margin of 23.5% led to adjusted EBITDA of $57.9 million, a 14% increase over last year.
Respiratory Supply Growth: Respiratory supply setups and deliveries increased to 480,000 for the year ended September 30, 2024, compared to 396,000 for the year ended September 30, 2023, reflecting a growth of 21%.
Customer Base Expansion: The customer base grew 10% year-over-year, serving 314,000 unique patients in fiscal year 2024 compared to 286,000 in fiscal year 2023.
Fiscal Year Revenue Increase: Revenue for fiscal year 2024 was $245.9 million compared to $211.7 million in fiscal year 2023, representing a 16.2% year-over-year increase.
Negative
Revenue Increase and Margin Decline: Revenue for fiscal year 2024 was $245.9 million compared to $211.7 million in fiscal year 2023, representing a 16.2% year-over-year increase, but adjusted EBITDA margin dropped from 24.5% in Q1 to 21.9% in Q4.
Adjusted EBITDA Decline: Adjusted EBITDA for fiscal Q4 2024 was $13.4 million, reflecting a 21.8% margin compared to $14.7 million at 24.6% margin in fiscal Q4 2023, representing an 8.8% decrease year-over-year.
Rising Operating Expense Ratio: Operating expenses as a percentage of revenue came in at 49.8% in fiscal year 2024 compared to 48.7% in the corresponding period in 2023, indicating increased cost pressures.
Decline in Cash Flow: Cash flow from continuing operations was $35.7 million for the 12 months ended September 30, 2024 compared to $37 million in the prior year, showing a decline in cash generation.
Debt Leverage Impact: The company reported a net debt to adjusted EBITDA leverage ratio of 1.6x, which limits flexibility to invest in strategic initiatives.
QIPT FAQs
How does QIPT typically perform around its earnings report dates?
Is Quipt Home Medical Corp. (QIPT) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
QIPT Earning Call Sentiment
Quipt Home Medical Corp. (QIPT) Q4 2024 Earnings Call Transcript
1.0x
00:00
00:00
QIPT.O
-2.55%Positive
Quipt's earnings call reflects a positive sentiment with a 15% revenue growth and a share repurchase program announcement. Despite challenges like a 2% gross margin decline and supply chain issues, the company showcases operational efficiency and a 10% net income increase. The Q&A reveals optimism about growth prospects and new product launches, although lacking specific revenue targets. Overall, the strategic expansion, patient-centric model, and financial improvements suggest a likely stock price increase of 2% to 8% over the next two weeks.
